NCT04009668 2024-10-30Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change DiseaseUniversity of MichiganPhase 2 Completed7 enrolled 12 charts
NCT00035334 2006-02-14Study of the Safety and Efficacy of NC-503 in Secondary (AA) AmyloidosisBellus Health Inc. - a GSK companyPhase 2/3 Completed150 enrolled